Resistin-Induced Endoplasmic Reticulum Stress Contributes to the Impairment of Insulin Signaling in Endothelium
Autor: | Lei Huang, Ruiping Cai, Weihong Li, Yueyang Liu, Jun Luo, Ming-Sheng Zhou, Aimei Wang |
---|---|
Rok vydání: | 2018 |
Předmět: |
0301 basic medicine
medicine.medical_specialty medicine.medical_treatment Adipokine 03 medical and health sciences Insulin resistance Enos Internal medicine medicine Pharmacology (medical) Protein kinase B resistin Pharmacology biology Chemistry Insulin lcsh:RM1-950 nutritional and metabolic diseases Correction respiratory system biology.organism_classification medicine.disease cardiovascular diseases endothelial nitric oxide synthesis Insulin receptor lcsh:Therapeutics. Pharmacology 030104 developmental biology Endocrinology biology.protein Unfolded protein response endoplasmic reticulum stress Resistin vascular insulin signaling hormones hormone substitutes and hormone antagonists |
Zdroj: | Frontiers in Pharmacology Frontiers in Pharmacology, Vol 9 (2018) |
ISSN: | 1663-9812 |
Popis: | Background: Endoplasmic reticulum (ER) stress plays an important role in the pathogenesis of obesity, insulin resistance and cardiovascular diseases (CVDs). Impairment of insulin vascular action may represent a mechanism linking insulin resistance and CVDs. The present study tested the hypothesis that adipocyte-derived resistin inhibits insulin-stimulated endothelial NO production through the induction of ER stress. Methods and Results: Human umbilical vein endothelial cells (HUVC) were incubated with tunicamycin (an inducer of ER stress, 1-20 μg/mL) or resistin (10-100 ng/mL) for 1 h. Either tunicamycin or resistin increased GRP78 (an ER stress marker) expression associated with the impairment of insulin-stimulated Akt/eNOS phosphorylation, which were prevented by TUDCA (an ER stress suppressor). Resistin increased reactive oxygen species (ROS) production, antioxidant treatment inhibited resistin-induced GRP78 expression and impairment of insulin Akt/eNOS signaling, suggesting that ROS may involve resistin-induced ER stress. Resistin also increased JNK phosphorylation, which was prevented by TUDCA. JNK inhibitor SP600125 relieved the resistin inhibitory effects on endothelial insulin Akt/eNOS signaling. In ex vivo experiments, the incubation of aortic rings with resistin impaired insulin- but not acetylcholine-induced vasodilation, which was restored by TUDCA. LNAME (a NOS inhibitor) abolished insulin-induced vasorelaxation in the control or the resistin-treated aortic rings. In addition, resistin increased the mRNA expressions of proinflammatory cytokines tumor nuclear factor (TNF)α and interleukin (IL)-1β, which were also prevented by TUDCA. Conclusion: Our results support the ideal that ER stress may play an important role for resistin impairment of vascular insulin signaling and insulin action. The mitigation of ER stress may represent a new strategy for prevention and treatment of CVDs in obesity and insulin resistant-related diseases. |
Databáze: | OpenAIRE |
Externí odkaz: |